Ending endorsements: GSK to change global marketing practices
By Shannon Ellis
Thursday, December 19, 2013
In a bid to modernize and put patients first, Glaxosmithkline plc has announced two marketing reforms that will be globally implemented in two years. In a Dec. 17 statement, GSK said it would remove individual sales targets from their sales force and end the practice of paying doctors for product endorsement.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.